Abstract:(Cell Stem Cell 4, 16–19; January 9, 2009) In our recent article, we unfortunately misquoted the findings in a recent study by Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar. When describing previous work using combination of the MEK inhibitor PD0325901 and the GSK3b inhibitor CHIR99021, our statement “Recent studies demonstrated that addition of the FGFR inhibitor PD173074 to the above cocktail is sufficient to maintain mESC pluripotency in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar).” was not accurate. Ying et al., in fact, used PD0325901 to replace PD1730474 and demonstrated maintenance of mESCs in the absence of LIF with these two factors only. The corrected section reads “Indeed, after serial passages, the growth of putative riPSCs treated with only PD0325901 and CHIR99021 declined, and the culture deteriorated due to the expansion of differentiated cells, although recent studies demonstrated that this combination of inhibitors can be used to maintain mESC self-renewal in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar). Because the TGFβ/Activin A/Nodal signaling cascade is essential to maintain undifferentiated hESCs and EpiSCs, but dispensable for mESC self-renewal, we tested whether the addition of an inhibitor of the type 1 TGFβ receptor, ALK5 (A-83-01), could help stabilize our riPSC cultures.” In addition, we omitted to mention that while our study was under review, Silva et al., 2008Silva J. Barrandon O. Nichols J. Kawaguchi J. Theunissen T.W. Smith A. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition.PLoS Biol. 2008; 6: 2237-2247https://doi.org/10.1371/journal.pbio.0060253Crossref Scopus (651) Google Scholar also published the use of these two inhibitors in the generation and propagation of mouse iPSCs. We apologize for any confusion caused. Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsLi et al.Cell Stem CellDecember 18, 2008In BriefConventional mouse and human embryonic stem cells (ESCs) can be typically derived by in vitro culture of blastocysts (Martin, 1981; Thomson et al., 1998), and induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells using defined genetic transduction methods (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). In both cases, different signaling pathways appear to regulate pluripotency with different characteristics in the two species. However, while rat ESC-like cells have been established based on certain traits (Demers et al., 2007; Ruhnke et al., 2003; Schulze et al., 2006; Ueda et al., 2008), to date, these lines fall short of exhibiting true pluripotency (e.g., fail to form teratoma or no/little contribution to chimerism) and thus cannot be considered authentic rat ESCs. Full-Text PDF Open Archive

Extremely low back facet feedback by quantum-confined Stark effect absorption in an edge-emitting light-emitting diode

Timely stimulation of early embryo promotes the acquisition of pluripotency

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Activin A and BMP4 Signaling Expands Potency of Mouse Embryonic Stem Cells in Serum-Free Media.

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

Digoxin bioavailability during quinidine administration

Derivation of hypermethylated pluripotent embryonic stem cells with high potency

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency

Donor embryonic stem cells impede host epiblast specification in 8-cell stage chimeras by crowding and FGF4 signalling

Pro-proliferating effect of homologous somatic cells on chicken primordial germ cells.

Establishment of Mouse Primed Stem Cells by Combination of Activin and LIF Signaling

Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo

Birth of Parthenote Mice Directly from Parthenogenetic Embryonic Stem Cells

In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells

HSPC117 Improves the Rate of Embryonic Development by Up-Regulating the Transcription of Proto-Oncogenes

Generation of Systemic Chimeras via Rabbit Induced Pluripotent Stem Cells Reprogrammed with KLF2, ERAS, and PRMT6

Author Correction: Formative Pluripotent Stem Cells Show Features of Epiblast Cells Poised for Gastrulation

Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cells

Derivation of new pluripotent stem cells from human extended pluripotent stem cells with formative features and trophectoderm potential

Relationship of PSC to embryos: Extending and refining capture of PSC lines from mammalian embryos